Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-02 Sale | 2024-10-07 5:47 pm | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer | 8,216 | $1.9836 | $16,298 | 47,757 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 5:20 pm | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer | 5,025 | $2.71 | $13,618 | 137,018 (Direct) | View |
| 2023-01-17 Sale | 2023-01-18 8:20 pm | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 3,575 | $5.74 | $20,521 | 96,047 (Direct) | View |
| 2022-01-18 Sale | 2022-01-19 6:19 pm | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 1,982 | $5.92 | $11,733 | 66,427 (Direct) | View |
| 2021-07-01 Sale | 2021-07-02 4:31 pm | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 942 | $13.6 | $12,811 | 0 (Direct) | View |
| 2021-01-19 Sale | 2021-01-20 7:03 pm | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 545 | $21.28 | $11,598 | 47,691 (Direct) | View |
| 2021-01-04 Sale | 2021-01-06 7:00 pm | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 247 | $26.76 | $6,610 | 0 (Direct) | View |
| 2020-06-30 Purchase | 2020-07-06 4:15 pm | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 3,383 | $4.87 | $16,475 | 0 (Direct) | View |
| 2020-07-02 Sale | 2020-07-06 4:15 pm | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 3,383 | $22.49 | $76,084 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-01 Exercise | 2024-10-07 5:47 pm | N/A N/A | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer | 30,000 | $0 | 47,757 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:20 pm | N/A 2034-01-14 | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer | 91,667 | $0 | 137,018 (Direct) | View |
| 2024-01-13 Exercise | 2024-01-17 5:20 pm | N/A N/A | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer | 12,780 | $0 | 137,018 (Direct) | View |
| 2023-09-05 Option Award | 2023-09-07 5:55 pm | N/A N/A | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-01-13 Option Award | 2023-01-18 8:20 pm | N/A 2033-01-12 | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 58,208 | $0 | 96,047 (Direct) | View |
| 2023-01-14 Exercise | 2023-01-18 8:20 pm | N/A N/A | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 10,136 | $0 | 96,047 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 6:19 pm | N/A 2032-01-13 | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 47,833 | $0 | 66,427 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-19 6:19 pm | N/A N/A | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 10,706 | $0 | 66,427 (Direct) | View |
| 2021-01-15 Tax Withholding | 2021-01-20 7:03 pm | N/A N/A | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 289 | $21.09 | 47,691 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 7:03 pm | N/A 2031-01-15 | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 45,192 | $0 | 47,691 (Direct) | View |
| 2021-01-15 Exercise | 2021-01-20 7:03 pm | N/A N/A | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 834 | $0 | 47,691 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-16 4:33 pm | N/A 2030-01-15 | Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller | 18,333 | $0 | 18,333 (Direct) | View |